GGrantIndex
← Search

Clinical Data Network Shared Resource

$4,700P30FY2018CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

Historically, it has been labor intensive for RPCI researchers to obtain accurate clinical data from multiple disparate sources in a HIPAA compliant manner. To improve efficiency, RPCI established the Clinical Data Network (CDN) Shared Resource, an operational network of people, databases and IT tools working together to consistently collect, abstract, retrieve, integrate, process, link to bio-specimens, and deliver clinical data in a cost-effective manner. It is the meaningful integration of people, research infrastructures and processes, and Information Technology (IT) resources that makes CDN a unique, nimble and effective shared resource. In fact, thanks to the CDN, researchers at RPCI today can get reliable clinical data in three to six days rather than the three to six weeks required before: In the two years of its existence, the CDN has been successfully developed into a shared resource, and seamlessly integrated into the RPCI translational research process. It is already being successfully used by an increasing number of CCSG peer reviewed members with high user satisfaction. The CDN is led by Carmelo Gaudioso, MD, MBA, PhD, Director of Biomedical Informatics. The CDN provides specialized data management technologies, services, and expertise to CCSG members conducting non-interventional research. It guides investigators through the protocol development process, including regulatory and data requirements, and facilitates the review and approval by Disease Site Research Groups (DSRGs) for their use of bio-specimens and data. It provides Honest Broker (HB) service for the delivery of de-identified data and the re-identification for the subsequent delivery of foliow-up data in a HIPAA compliant manner. To establish interoperability across the disparate databases and facilitate data integration and sharing, the CDN facilitates the creation and adoption of standard data dictionaries and data standards. The CDN collaborates with other Shared Resources, notably the Pathology Resource Network (PRN) and the Data Bank and BioRepository (DBBR), for the annotation and the selection of bio-specimens based on clinical-pathological characteristics. To improve the value of the services provided to CCSG members. Dr. Gaudioso and his staff work closely with the scientific programs to better understand their research and related data requirements. First priority for use is given to peer-review-funded RPCI CCSG members; second priority to non-peer-review- funded CCSG members; third priority to non-members and academic collaborators; and last priority to external users. During the reporting period, the Clinical Data Network Shared Resource has served 28 members from 6 research programs, with 37% utilization by CCSG members with peer reviewed funding. The CCSG support provides 6% of the overall proposed budget.

View original record on NIH RePORTER →